The potential risks of dabigatran are not appreciated, particularly where the elderly are concerned, according to a letter written by researchers who tracked bleeding events in patients who took the drug. ... The audit shows that it's difficult to
Researcher aims to assess beta-blocker use in patients with pacemakers.
The researchers became concerned when they noticed that several clinical study and review authors had concluded chlorhexidine was superior to povidone-iodine, though the studies/reviews themselves had pitted a combination ... While the researchers found
The researchers defined “marijuana-related” as any ED visit where use of marijuana was implicated either as a direct cause or contributing factor of the visit, Dr.
The researchers noted that their results were vulnerable to selection bias and may not be generalizable to other critically ill populations, among other limitations. ... Researchers conducted a quasi-experimental, pre-post implementation study of the
To test the program's effect on readmissions, researchers randomly assigned 800 hospitalized patients with medically and socially complex conditions and at least one additional hospitalization in the prior six months
Researchers sought to determine the relationship between stopping digoxin and outcomes among hospitalized patients with heart failure and an ejection fraction of 45% or less. ... Digoxin was discontinued before discharge in 721 patients, and researchers
Australian researchers conducted a prospective, population-based, active surveillance study of iGAS infections in the state of Victoria from March 2002 through August 2004. ... The program has led to a decrease in nebulizer rates of more than 50% on a
The audit shows that it's difficult to translate trial data into clinical practice, and it's important to conduct postmarketing surveillance and adverse-event reporting, the researchers noted. ... Dutch researchers performed a case-control study in nine
In addition, we'll include more Q&As with researchers, clinicians and thought leaders about new developments and contributions in the field.